Physician-Patient Alliance for Health & Safety

CPD Standards Office Provider Number: 22061

Send an enquiry

Send an enquiry to this training provider

Name(Required)

Surname(Required)

Phone

Email(Required)

Message(Required)

This field is hidden when viewing the form

Email of contact

This field is hidden when viewing the form

CPD Standards Office Provider ID

This field is hidden when viewing the form

Accredited Activities

<ul>
 	<li>Respiratory Compromise Prevention, Recognition and Intervention</li>
 	<li>Advances in Lung Imaging</li>
 	<li>4th World Sepsis Congress CME</li>
 	<li>S2: The Health Economic and Human Burden of Infections and Pandemics</li>
 	<li>S3: Overcoming Silos to Address Infection-Related Global Health Threats</li>
 	<li>S4: The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics</li>
 	<li>S6: Advances in Timely Pathogen and Sepsis Detection</li>
 	<li>S7: The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level</li>
 	<li>S8: The Potential and Challenges to Intervene with the Immune Response</li>
 	<li>S9: Biomarkers and Antimicrobial Stewardship - The Synergies to Diagnose Sepsis and to Prevent AMR</li>
 	<li>S10: Lessons from the Pandemic to Fight Common Infections and Sepsis</li>
 	<li>S11: Understanding and Improving Long-term Outcomes After Sepsis and COVID-19</li>
 	<li>S12: Neonatal Sepsis Platforms and Guidelines</li>
 	<li>S14: Maternal Sepsis: Why Is It Still in The Top 3 for Global Incidence of Sepsis</li>
 	<li>S16: An Update on Research on Sepsis</li>
 	<li>Humidified High Flow Therapy of High-Velocity Nasal Insufflation</li>
 	<li>Weaning Approaches</li>
 	<li>Culture of Weaning</li>
 	<li>Resident Selection</li>
 	<li>Process Improvement &amp; Discharge</li>
 	<li>Quality of Life</li>
 	<li>Ventilator Unit Technology &amp; Equipment</li>
 	<li>The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients</li>
 	<li>Data, AI and Predictive Modeling in Sepsis</li>
 	<li>Detecting Sepsis in the Ventilated Patient</li>
 	<li>How Does Dypervolemia Increase the Mortality Risk in Sepsis?</li>
 	<li>Personalized Approaches to Sepsis Management</li>
 	<li>Challenges and Solutions for Early Recognition and Treatement of Sepsis</li>
 	<li>Closing the Needs in Pediatric Sepsis</li>
 	<li>The Role of Biomarkers in the Early Detection of Sepsis</li>
</ul>

This field is hidden when viewing the form

Who should attend

This field is hidden when viewing the form

Main Website

CAPTCHA

Category: Health & Safety, Healthcare & Pharmaceuticals, Medical

Description:

PPAHS is a national advocacy force for addressing patient health and safety priorities that are shared by patients, physicians, regulators and industry. By doing so, we seek to ensure that the best medications, medical invention and technology that can improve care and reduce cost are employed. PPAHS works to advance patient health and safety by developing and highlighting best practices and recommendations through better use and application of clinical practices and experiences, information technologies and checklists, and healthcare information. As a voice in support of ideas and innovation that can improve care, we encourage a health ecosystem that fosters a culture of patient safety.

Accredited Activities:

Respiratory Compromise Prevention, Recognition and Intervention
Advances in Lung Imaging
4th World Sepsis Congress CME
S2: The Health Economic and Human Burden of Infections and Pandemics
S3: Overcoming Silos to Address Infection-Related Global Health Threats
S4: The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics
S6: Advances in Timely Pathogen and Sepsis Detection
S7: The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level
S8: The Potential and Challenges to Intervene with the Immune Response
S9: Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR
S10: Lessons from the Pandemic to Fight Common Infections and Sepsis
S11: Understanding and Improving Long-term Outcomes After Sepsis and COVID-19
S12: Neonatal Sepsis Platforms and Guidelines
S14: Maternal Sepsis: Why Is It Still in The Top 3 for Global Incidence of Sepsis
S16: An Update on Research on Sepsis
Humidified High Flow Therapy of High-Velocity Nasal Insufflation
Weaning Approaches
Culture of Weaning
Resident Selection
Process Improvement & Discharge
Quality of Life
Ventilator Unit Technology & Equipment
The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients
Data, AI and Predictive Modeling in Sepsis
Detecting Sepsis in the Ventilated Patient
How Does Dypervolemia Increase the Mortality Risk in Sepsis?
Personalized Approaches to Sepsis Management
Challenges and Solutions for Early Recognition and Treatement of Sepsis
Closing the Needs in Pediatric Sepsis
The Role of Biomarkers in the Early Detection of Sepsis

Who Should Attend:

Clinicians, hospital executives, and risk managers.

Further Information:

http://www.ppahs.org/